BCL2L1 and acute myeloid leukemia: With respect to the BCL-XL inhibitor A1331825, PL-21 and MOLM-16 cells were susceptible with IC50 of 2–4 μM, while other AML cell lines were resilient with IC50 values of 5–10 μM.